Literature DB >> 6247503

Relationship among Tau antigens isolated from various lines of simian virus 40-transformed cells.

D T Simmons, M A Martin, P T Mora, C Chang.   

Abstract

In addition to the virus-specified tumor antigens, simian virus 40-transformed cells contain at least one other protein which can be immunoprecipitated with serum from animals bearing simian virus 40-induced tumors. This protein, which is designated Tau antigen, has an apparent molecular weight of 56,000 as determined by electrophoresis on acrylamide gels. The relationship among Tau antigens isolated from different lines of simian virus 40-transformed cells was examined by comparing the methionine-labeled tryptic peptides of these proteins by two-dimensional fingerprinting on thin-layer cellulose plates. In this fashion, we initially determined that the Tau antigens isolated from three different lines of transformed mouse cells were very similar. Second, we found that Tau antigen isolated from a line of rat transformants was closely related, but not identical, to the mouse cell Tau antigens. Approximately 70% of their methionine peptides comigrated in two dimensions. Finally, we showed that Tau antigen isolated from a line of transformed human cells was only partially related to the mouse and rat proteins. About 40% of the methionine peptides of the human protein were also contained in the Tau antigens from the other two species. These results strongly indicate that the Tau antigens isolated from these various simian virus 40-transformed cell lines contain common amino acid sequences.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247503      PMCID: PMC288753     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Regulation of tumor antigen synthesis by simain virus 40 gene A.

Authors:  P Tegtmeyer; M Schwartz; J K Collins; K Rundell
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

2.  The arrangement of simian virus 40 sequences in the DNA of transformed cells.

Authors:  M Botchan; W Topp; J Sambrook
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

3.  Polyoma virus proteins: a description of the structural proteins of the virion based on polyacrylamide gel electrophoresis and peptide analysis.

Authors:  W Gibson
Journal:  Virology       Date:  1974-12       Impact factor: 3.616

4.  The use of protein A-containing Staphylococcus aureus as a solid phase anti-IgG reagent in radioimmunoassays as exemplified in the quantitation of alpha-fetoprotein in normal human adult serum.

Authors:  S Jonsson; G Kronvall
Journal:  Eur J Immunol       Date:  1974-01       Impact factor: 5.532

5.  Induction of DNA synthesis by SV40.

Authors:  M Hatanaka; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

6.  Stimulation of DNA synthesis and complement-fixing antigen production by SV40 in human diploid cell cultures: evidence for "abortive" infection.

Authors:  G Sauer; V Defendi
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

7.  Useful buffer and gel systems for polyacrylamide gel electrophoresis.

Authors:  H R Maurer; R C Allen
Journal:  Z Klin Chem Klin Biochem       Date:  1972-05

8.  Two forms of simian-virus-40-specific T-antigen in abortive and lytic infection.

Authors:  C Ahmad-Zadeh; B Allet; J Greenblatt; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Susceptibility of human diploid fibroblast strains to transformation by SV40 virus.

Authors:  G J Todaro; H Green; M R Swift
Journal:  Science       Date:  1966-09-09       Impact factor: 47.728

10.  Monomer molecular weight of T antigen from simian virus 40-infected and transformed cells.

Authors:  R B Carroll; A E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  21 in total

1.  Mapping of helicase and helicase substrate-binding domains on simian virus 40 large T antigen.

Authors:  K Wun-Kim; D T Simmons
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Phosphorylation downregulates the DNA-binding activity of simian virus 40 T antigen.

Authors:  D T Simmons; W Chou; K Rodgers
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53.

Authors:  F I Schmieg; D T Simmons
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

Review 4.  Tumor viruses and early mouse embryos.

Authors:  F Kelly; H Condamine
Journal:  Biochim Biophys Acta       Date:  1982-04-29

5.  Stabilization of the 53,000-dalton nonviral tumor antigen is not required for transformation by simian virus 40.

Authors:  L M Sompayrac; E G Gurney; K J Danna
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

6.  A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species.

Authors:  H Jörnvall; J Luka; G Klein; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  An oligomeric form of simian virus 40 large T-antigen is immunologically related to the cellular tumor antigen p53.

Authors:  K N Leppard; L V Crawford
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  Characterization of tau antigens isolated from uninfected and simian virus 40-infected monkey cells and papovavirus-transformed cells.

Authors:  D T Simmons
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells.

Authors:  E Harlow; D C Pim; L V Crawford
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

10.  Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Authors:  D Wolf; V Rotter
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.